🔗 Share this article

An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Investigational Treatment Acquiring Traction Online

Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed fat-burning effects. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Sellers promote the substance there before redirecting customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Express Worries

However, doctors and pharmacists have cautions that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals administering products of uncertain source.

Several professionals stated the popularity for retatrutide could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for human use under the British medical regulations.

Several influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment.

Service Response and Content Elimination

Based on TikTok, the service has removed problematic content and banned related keywords and query recommendations. The company stated it was dedicated to maintaining the service secure and investing in strengthening compliance measures.

Online Trading Activities

Research also found communities with up to 9,000 participants selling retatrutide using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly brings up channels with thousands of users, filled with images of weight loss, glowing testimonials and step-by-step instructions for mixing or injecting at home.

After moments of entering one community, a seller posted contact information, where most purchases occur. The vendor sent an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, health issues or past usage.

Item Information and Costs

Within these groups, posts display black plastic parcels with Royal Mail labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use pens typically priced at £160 for 20 milligrams. When asked how long a pen should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service stated it regularly monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they can’t verify. Even if the research behind this drug is sound, these online products may not contain what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the surge in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.

Her team has already encountered patients harmed by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company investigational substance not yet authorized … may expose users to potentially serious health risks”.